- Home
- Publications
- Publication Search
- Publication Details
Title
Metronomics: towards personalized chemotherapy?
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 11, Issue 7, Pages 413-431
Publisher
Springer Nature
Online
2014-06-10
DOI
10.1038/nrclinonc.2014.89
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pilot study of a pediatric metronomic 4-drug regimen
- (2015) Nicolas André et al. Oncotarget
- Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
- (2015) Eddy Pasquier et al. Oncotarget
- Tumors That Acquire Resistance to Low-Dose Metronomic Cyclophosphamide Retain Sensitivity to Maximum Tolerated Dose Cyclophosphamide
- (2015) Urban Emmenegger et al. NEOPLASIA
- Intermittent Metronomic Drug Schedule Is Essential for Activating Antitumor Innate Immunity and Tumor Xenograft Regression
- (2015) Chong-Sheng Chen et al. NEOPLASIA
- A Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy
- (2014) Rebekka Kubisch et al. Translational Oncology
- Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study
- (2013) Evangelos Briasoulis et al. BMC CANCER
- Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial
- (2013) Diana Crivellari et al. BREAST
- Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis
- (2013) Robert S. Kerbel et al. BREAST
- β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma
- (2013) E Pasquier et al. BRITISH JOURNAL OF CANCER
- A phase 1 trial of imatinib, bevacizumab and metronomic cyclophosphamide in advanced colorectal cancer
- (2013) R K Kelley et al. BRITISH JOURNAL OF CANCER
- Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
- (2013) James Kim et al. CANCER CELL
- A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens
- (2013) C. Faivre et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Center of Cancer Systems Biology Second Annual Workshop--Tumor Metronomics: Timing and Dose Level Dynamics
- (2013) P. Hahnfeldt et al. CANCER RESEARCH
- Formalizing an Integrative, Multidisciplinary Cancer Therapy Discovery Workflow
- (2013) M. F. McGuire et al. CANCER RESEARCH
- The Evolution of Melanoma Resistance Reveals Therapeutic Opportunities
- (2013) M. D. Thakur et al. CANCER RESEARCH
- Oral Metronomic Chemotherapy in Recurrent, Metastatic and Locally Advanced Head and Neck Cancers
- (2013) V. Patil et al. CLINICAL ONCOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
- (2013) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients
- (2013) Herman A Perroud et al. Future Oncology
- Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma
- (2013) X. Papanikolaou et al. HAEMATOLOGICA
- Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02
- (2013) F Traore et al. INDIAN JOURNAL OF CANCER
- Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: A matched-pair analysis
- (2013) SD Banavali et al. INDIAN JOURNAL OF CANCER
- Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells
- (2013) Marta Vives et al. INTERNATIONAL JOURNAL OF CANCER
- Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy
- (2013) Annabelle Chow et al. INVESTIGATIONAL NEW DRUGS
- A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group
- (2013) Emmanouil Kontopodis et al. JOURNAL OF CHEMOTHERAPY
- The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
- (2013) Emma L. Barber et al. Journal of Gynecologic Oncology
- Cooperativity of CD44 and CD49d in Leukemia Cell Homing, Migration, and Survival Offers a Means for Therapeutic Attack
- (2013) V. Singh et al. JOURNAL OF IMMUNOLOGY
- Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results
- (2013) Andrea Salmaggi et al. JOURNAL OF NEUROSURGERY
- Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers
- (2013) Sébastien Benzekry et al. JOURNAL OF THEORETICAL BIOLOGY
- Has the time come for metronomics in low-income and middle-income countries?
- (2013) Nicolas André et al. LANCET ONCOLOGY
- Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
- (2013) Ilkka Liikanen et al. MOLECULAR THERAPY
- Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy
- (2013) Liming Weng et al. PHARMACOGENOMICS
- The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
- (2013) Sean M. Geary et al. PLoS One
- A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
- (2013) N. S. Jahchan et al. Cancer Discovery
- Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
- (2013) Matilde Todaro et al. OncoImmunology
- Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
- (2013) Lana E. Kandalaft et al. OncoImmunology
- Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells
- (2012) Eddy Pasquier et al. ANGIOGENESIS
- Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
- (2012) Giacomo Allegrini et al. ANGIOGENESIS
- Network-enabled gene expression analysis
- (2012) David Edwards et al. BMC BIOINFORMATICS
- Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab
- (2012) Silvia Dellapasqua et al. BREAST
- Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics
- (2012) Erica L. Mayer et al. BREAST CANCER RESEARCH AND TREATMENT
- Oral Metronomic Cyclophosphamide and Methotrexate Plus Fulvestrant in Advanced Breast Cancer Patients: A Mono-Institutional Case-Cohort Report
- (2012) Gaetano Aurilio et al. Breast Journal
- Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
- (2012) P D Dickinson et al. BRITISH JOURNAL OF CANCER
- Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer
- (2012) Masataka Yoshimoto et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
- (2012) Raffaele Addeo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
- (2012) Eva Ellebaek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
- (2012) Emilia Montagna et al. Clinical Breast Cancer
- A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
- (2012) S. Kummar et al. CLINICAL CANCER RESEARCH
- Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer
- (2012) S.D. Young et al. Current Oncology
- Drug repurposing in pediatrics and pediatric hematology oncology
- (2012) Julie Blatt et al. DRUG DISCOVERY TODAY
- Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours
- (2012) Anna Koumarianou et al. ENDOCRINE-RELATED CANCER
- Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma – A report from the Société Française des Cancers et leucémies de l’Enfant et de l’adolescent (SFCE)
- (2012) Véronique Minard-Colin et al. EUROPEAN JOURNAL OF CANCER
- The person in personalised medicine
- (2012) François Doz et al. EUROPEAN JOURNAL OF CANCER
- Ischaemia-induced mucus barrier loss and bacterial penetration are rapidly counteracted by increased goblet cell secretory activity in human and rat colon
- (2012) Joep Grootjans et al. GUT
- Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α
- (2012) Yeo-Jung Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Interaction between regulatory T cells and cancer stem cells
- (2012) Xiaozhou Yu et al. INTERNATIONAL JOURNAL OF CANCER
- Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cellsin vitroin a TLR4-independent manner
- (2012) Tillmann Michels et al. Journal of Immunotoxicology
- Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts
- (2012) Ines Martin-Padura et al. LABORATORY INVESTIGATION
- Addition of an induction regimen of antiangiogenesis and antitumor immunity to standard chemotherapy improves survival in advanced malignancies
- (2012) Eduardo Lasalvia-Prisco et al. MEDICAL ONCOLOGY
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- (2012) Mélanie Bruchard et al. NATURE MEDICINE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Neurocognitive function after radiotherapy for paediatric brain tumours
- (2012) Laetitia Padovani et al. Nature Reviews Neurology
- Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
- (2012) Antonio Omuro et al. NEURO-ONCOLOGY
- Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience
- (2012) D. Zapletalova et al. ONCOLOGY
- Metronomic Oral Cyclophosphamide in Patients with Advanced Solid Tumors
- (2012) Peter Bojko et al. ONKOLOGIE
- A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893
- (2012) Judy L. Felgenhauer et al. PEDIATRIC BLOOD & CANCER
- Generalized principles of stochasticity can be used to control dynamic heterogeneity
- (2012) David Liao et al. PHYSICAL BIOLOGY
- Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer
- (2012) Kevin C. Foy et al. OncoImmunology
- Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
- (2012) Mariana Malvicini et al. OncoImmunology
- Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer
- (2011) Silvia Dellapasqua et al. BREAST
- Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
- (2011) O A Khan et al. BRITISH JOURNAL OF CANCER
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
- (2011) Pierpaolo Correale et al. CANCER BIOLOGY & THERAPY
- Phase I trial of metronomic oral vinorelbine in patients with advanced cancer
- (2011) Lakshmi Rajdev et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
- (2011) Zacharenia Saridaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study
- (2011) Zhonghua Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Chemoresistance to Temozolomide in Human Glioma Cell Line U251 is Associated with Increased Activity of O 6-methylguanine-DNA Methyltransferase and Can be Overcome by Metronomic Temozolomide Regimen
- (2011) Qiang Pan et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor
- (2011) S. Kumar et al. CLINICAL CANCER RESEARCH
- Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1 in Advanced Solid Tumors
- (2011) S. Kummar et al. CLINICAL CANCER RESEARCH
- Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma
- (2011) Olivier Mir et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer
- (2011) P. Fedele et al. EUROPEAN JOURNAL OF CANCER
- Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma
- (2011) Alfredo Berruti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity
- (2011) Sophie R. Sierro et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma
- (2011) Jeong Won Jang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?
- (2011) Nicolas André et al. Future Oncology
- A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study
- (2011) Robert S. Mannel et al. GYNECOLOGIC ONCOLOGY
- Evaluation of oral chemotherapy with capecitabine and cyclophosphamide plus thalidomide and prednisone in prostate cancer patients
- (2011) Li-Juan Meng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer
- (2011) Martin R. Stockler et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II Randomized Trial of Gefitinib Alone or with Tegafur/Uracil Treatment in Patients with Pulmonary Adenocarcinoma Who had Failed Previous Chemotherapy
- (2011) Yuh-Min Chen et al. Journal of Thoracic Oncology
- Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
- (2011) B. Walter et al. MEDICAL ONCOLOGY
- Capecitabine “metronomic” chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy
- (2011) ShengLi He et al. MEDICAL ONCOLOGY
- Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer
- (2011) R. De Souza et al. MOLECULAR CANCER THERAPEUTICS
- Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis
- (2011) G. Francia et al. MOLECULAR CANCER THERAPEUTICS
- Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus
- (2011) Vincenzo Cerullo et al. MOLECULAR THERAPY
- Integrating pharmacogenetics into gemcitabine dosing—time for a change?
- (2011) Joseph Ciccolini et al. Nature Reviews Clinical Oncology
- Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors
- (2011) Andreas Peyrl et al. PEDIATRIC BLOOD & CANCER
- Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44+ Cells and Evidence for Epigenetic Mechanisms
- (2011) Hong Yan et al. PLoS One
- Control Dominating Subclones for Managing Cancer Progression and Posttreatment Recurrence by Subclonal Switchboard Signal: Implication for New Therapies
- (2011) Shengwen Calvin Li et al. STEM CELLS AND DEVELOPMENT
- Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration-refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel
- (2011) Vittorio Gebbia et al. UROLOGY
- Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
- (2011) Ramon Kaneno et al. CELLULAR ONCOLOGY
- Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas
- (2010) Sanna-Maria Kivivuori et al. ACTA PAEDIATRICA
- Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed?
- (2010) C. Zielinski et al. ANNALS OF ONCOLOGY
- Metronomic gemcitabine suppresses tumour growth, improves perfusion and reduces hypoxia in human pancreatic ductal adenocarcinoma
- (2010) K K Y Cham et al. BRITISH JOURNAL OF CANCER
- A phase 2 pilot trial of low-dose, continuous infusion, or “metronomic” paclitaxel and oral celecoxib in patients with metastatic melanoma
- (2010) Rupal S. Bhatt et al. CANCER
- A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC
- (2010) Athanasios G. Pallis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Selective Depletion of CD4+CD25+Foxp3+Regulatory T Cells by Low-Dose Cyclophosphamide Is Explained by Reduced Intracellular ATP Levels
- (2010) Jie Zhao et al. CANCER RESEARCH
- Knockout of HIF-1 in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses
- (2010) C. Werno et al. CARCINOGENESIS
- A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma
- (2010) Julia R. Sharp et al. EUROPEAN JOURNAL OF CANCER
- Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapy
- (2010) Amélie Lansiaux et al. INVESTIGATIONAL NEW DRUGS
- The influence of TXNDC5 gene on gastric cancer cell
- (2010) Lin Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Vinblastine in Children and Adolescents With High-Risk Anaplastic Large-Cell Lymphoma: Results of the Randomized ALCL99-Vinblastine Trial
- (2010) Marie-Cécile Le Deley et al. JOURNAL OF CLINICAL ONCOLOGY
- Looking at the Seemingly Contradictory Role of Vinblastine in Anaplastic Large-Cell Lymphoma From a Metronomic Perspective
- (2010) Nicolas André et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma
- (2010) Chih-Hung Hsu et al. JOURNAL OF HEPATOLOGY
- Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy
- (2010) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Nontoxic, Fiscally Responsible, Future of Oncology
- (2010) Giannoula Lakka Klement et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Children Treated With Metronomic Chemotherapy in a Low-income Country
- (2010) Traore Fousseyni et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy
- (2010) Lilja Thoenes et al. Journal of Proteomics
- Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)
- (2010) Joaquim Bellmunt et al. LANCET ONCOLOGY
- Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer
- (2010) H. S. Tran Cao et al. MOLECULAR CANCER THERAPEUTICS
- Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined with the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer
- (2010) Kae Hashimoto et al. MOLECULAR CANCER THERAPEUTICS
- Metronomic Chemotherapy Enhances Antitumor Effects of Cancer Vaccine by Depleting Regulatory T Lymphocytes and Inhibiting Tumor Angiogenesis
- (2010) Chi-An Chen et al. MOLECULAR THERAPY
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer
- (2010) Alfonso Sánchez-Muñoz et al. ONCOLOGY
- A phase II study of metronomic oral topotecan for recurrent childhood brain tumors
- (2010) Jane E. Minturn et al. PEDIATRIC BLOOD & CANCER
- Embryonal rhabdomyosarcoma with metastases confined to the lungs: Report from the CWS Study Group
- (2010) Tobias M. Dantonello et al. PEDIATRIC BLOOD & CANCER
- A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study
- (2010) Heidi V. Russell et al. PEDIATRIC BLOOD & CANCER
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adaptive Therapy
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2-Positive Human Breast Cancer Xenografts
- (2009) G. Francia et al. CLINICAL CANCER RESEARCH
- Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)
- (2009) J. Doloff et al. CURRENT CANCER DRUG TARGETS
- Single-Drug Vinblastine As Salvage Treatment for Refractory or Relapsed Anaplastic Large-Cell Lymphoma: A Report From the French Society of Pediatric Oncology
- (2009) Laurence Brugières et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial
- (2009) Toru Watanabe et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
- (2009) Ramon Kaneno et al. Journal of Translational Medicine
- A change of strategy in the war on cancer
- (2009) Robert A. Gatenby NATURE
- For cancer, seek and destroy or live and let live?
- (2009) Nicolas André et al. NATURE
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
- (2009) Ching-Hon Pui et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Using Pharmacokinetic and Pharmacodynamic Modeling and Simulation to Evaluate Importance of Schedule in Topotecan Therapy for Pediatric Neuroblastoma
- (2008) J. C. Panetta et al. CLINICAL CANCER RESEARCH
- A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer
- (2008) M. N. Dickler et al. CLINICAL CANCER RESEARCH
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
- The prince and the pauper. A tale of anticancer targeted agents
- (2008) Alfonso Dueñas-González et al. Molecular Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation